Pharma/fine chemicals roundup—23 October

Mylan buys API plant in India Active pharmaceutical ingredients (API), intermediates and formulations manufacturer SMS Pharmaceuticals (Hyderabad, India) informed the Bombay Stock Exchange (Mumbai) that its board of directors has decided to sell its plant at Visakhapatnam, India, to Mylan Laboratories (Hyderabad), a subsidiary of Mylan (Canonsburg, PA), for 1.73 billion Indian rupees ($33 million). The plant manufactures APIs and formulations for oncology drugs. AMRI extends API supply deal with Shire Albany Molecular Research Inc. (AMRI; Albany) says it has...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers